On this page
Genitopatellar syndrome
Genitopatellar syndrome is a rare genetic condition that primarily affects development, leading to intellectual disability, skeletal abnormalities, and genital differences. It is present from birth and impacts multiple body systems, requiring lifelong supportive care.
Available at Jeen Health
Clinical tests that include this
Overview
Genitopatellar syndrome is a rare, complex genetic condition that affects various parts of the body, including the brain, skeleton, and genitourinary system [PMID:33671234]. Individuals with this syndrome typically experience developmental delay and intellectual disability. Other common features include distinctive facial characteristics, such as a prominent forehead and widely spaced eyes, as well as patellar agenesis (absence) or hypoplasia (underdevelopment). The condition is present from birth and its severity can vary among affected individuals. It is considered a neurodevelopmental disorder due to its impact on brain development and function [PMID:24270183].
Symptoms & clinical features
The symptoms of Genitopatellar syndrome are diverse and can affect multiple body systems. Developmental delay is a key feature, often leading to intellectual disability, which can range from mild to severe. Many individuals exhibit distinctive facial features, including a prominent forehead, widely spaced eyes (hypertelorism), a small nose, and a thin upper lip. Skeletal abnormalities are common, particularly affecting the knees, where the kneecaps (patellae) may be absent or unusually small [PMID:24270183].
Other notable features can include abnormalities of the genitals, such as undescended testes (cryptorchidism) in males or structural differences in females. Some individuals may have brain abnormalities detected through imaging, such as an underdeveloped corpus callosum, the structure connecting the two halves of the brain. Additional features that have been reported include hearing loss, feeding difficulties in infancy, and various congenital anomalies affecting other organ systems [PMID:31580977].
Video: Genetics 101
Affected organs
Genitopatellar syndrome impacts several crucial organ systems. The brain is significantly affected, leading to developmental delay and intellectual disability, and sometimes structural anomalies like an aberrant corpus callosum or cerebellar hypoplasia. The skeletal system is notably involved, with the patellae (kneecaps) often being absent or underdeveloped. Other skeletal features can include joint contractures (reduced range of motion) and abnormalities of the hands and feet.
The genitourinary system is also commonly affected, with genital anomalies such as undescended testicles in males being reported. Kidney abnormalities have also been observed, though less frequently. Other organ systems that may be affected include the heart, with congenital heart defects in some cases, and the eyes, with reported visual impairments. Feeding difficulties often stem from neurological or structural challenges impacting oral motor skills.
Risks & severity
Genitopatellar syndrome presents a spectrum of severity; however, it is generally considered a severe developmental disorder. The intellectual disability typically ranges from moderate to severe, significantly impacting an individual's ability to live independently. The skeletal abnormalities, particularly affecting the knees, can impact mobility and require orthopaedic management.
Due to the rarity of the condition, exact lifetime risks for specific complications are not well established. However, the presence of multiple congenital anomalies and profound developmental challenges means that individuals often require lifelong, multidisciplinary medical care and support. The age of onset is congenital, meaning the features are present from birth, although developmental delays become more apparent as a child grows.
Genetic causes
Genitopatellar syndrome is caused by pathogenic variants in the KAT6B gene. The KAT6B gene provides instructions for making an enzyme known as lysine acetyltransferase 6B. This enzyme plays a crucial role in modifying proteins called histones. Histones act like spools around which DNA is wound, and their modification helps regulate gene expression - the process by which genes are switched on or off [PMID:24270183].
The KAT6B enzyme is particularly important during early embryonic development, influencing the formation of various tissues and organs, including the nervous and skeletal systems. Pathogenic variants in KAT6B disrupt the normal function of this enzyme, leading to errors in gene regulation. This in turn affects critical developmental pathways, resulting in the characteristic features observed in Genitopatellar syndrome.
- KAT6B lysine acetyltransferase 6BThe *KAT6B* gene provides instructions for an enzyme involved in modifying histone proteins, which plays a critical role in regulating gene activity during development.
Inheritance pattern
Genitopatellar syndrome is inherited in an autosomal dominant pattern. This means that a person needs only one copy of an altered KAT6B gene to develop the condition. In most cases, the pathogenic variant arises spontaneously (de novo) in the affected individual and is not inherited from either parent. This means neither parent carries the altered gene in their germline cells. If a pathogenic variant is de novo, the risk of it occurring again in future children of unaffected parents is generally very low, though there is a small theoretical risk of germline mosaicism.
However, if an affected individual with Genitopatellar syndrome has children, each child would have a 50% chance of inheriting the altered gene and therefore developing the condition, regardless of their sex. Genetic counselling can provide detailed information about inheritance risks for individual families.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosing Genitopatellar syndrome typically involves a combination of clinical evaluation and genetic testing. A paediatrician or clinical geneticist may suspect the condition based on the presence of characteristic features such as developmental delay, intellectual disability, distinctive facial features, and skeletal abnormalities of the patella. Imaging studies, such as brain MRI and skeletal X-rays, can help to identify specific anomalies.
Confirmation of the diagnosis requires genetic testing to identify a pathogenic variant in the KAT6B gene. This testing is usually performed through a blood sample and can be part of broader genomic testing, such as whole exome sequencing or specific gene panel testing. In the UK, genetic testing for developmental disorders falls under the NHS Genomic Medicine Service (GMS) and is often accessed via an R-code, with referrals typically made by clinical geneticists or specialist paediatricians. Genetic counsellors can help families navigate the diagnostic process and understand the implications of a confirmed diagnosis.
Management & lifestyle
Management of Genitopatellar syndrome is multidisciplinary and focuses on addressing the individual's specific symptoms and needs. There is no cure for the condition, so treatment is supportive. Early intervention programmes, including physiotherapy, occupational therapy, and speech and language therapy, are crucial for optimising developmental outcomes. Educational support tailored to the intellectual disability is also essential.
Individuals with Genitopatellar syndrome often require ongoing medical surveillance. This may involve regular follow-ups with paediatricians, neurologists, orthopaedic specialists for skeletal issues, and urologists for genitourinary anomalies. Surgical interventions may be considered for severe skeletal abnormalities or other congenital defects. Genetic counsellors play a vital role in supporting families, providing information, and connecting them with appropriate services and support networks within the NHS framework.
UK care pathway
In the UK, suspected cases of rare genetic conditions like Genitopatellar syndrome are typically referred to a Clinical Genetics service. This pathway involves assessment by specialist doctors and genetic counsellors who can guide families through the diagnostic process. Genetic testing, often under an NHS R-code (e.g., R14 - Intellectual disability), is performed to identify the genetic cause. If a diagnosis is confirmed, care then shifts to a multidisciplinary team model, engaging various paediatric specialities and local community support services within the NHS. Genetic counsellors remain a key point of contact for ongoing support and information regarding inheritance and family planning.
Frequently asked questions
Is Genitopatellar syndrome inherited from my parents?
In most cases, Genitopatellar syndrome is not inherited from parents. The genetic change in the KAT6B gene often arises spontaneously in the affected child, meaning it was not present in either parent's germline cells. However, genetic counselling can provide specific information about your family's situation.
What kind of support is available for a child with Genitopatellar syndrome?
Support for a child with Genitopatellar syndrome in the UK is typically managed by a multidisciplinary team within the NHS. This can include paediatricians, neurologists, orthopaedic specialists, and therapists (physio, occupational, speech & language). Educational support and community services are also vital for addressing developmental needs.
What are the long-term prospects for someone with Genitopatellar syndrome?
Genitopatellar syndrome is a lifelong condition associated with significant developmental challenges and intellectual disability. The long-term prospects vary depending on the severity of symptoms and the presence of associated medical complications. Ongoing supportive and symptomatic care is essential to improve quality of life.
Will my future children be affected if I have one child with Genitopatellar syndrome?
If your child's Genitopatellar syndrome is due to a spontaneous (de novo) genetic change, the risk to your future children is generally considered very low, though a small theoretical risk of parental germline mosaicism exists. A genetic counsellor can discuss your family's specific situation and recurrence risks in detail.
How is Genitopatellar syndrome related to the KAT6B gene?
Genitopatellar syndrome is caused by pathogenic variants in the KAT6B gene. This gene produces an enzyme vital for modifying histones, which helps regulate gene activity during early development. When the KAT6B gene doesn't function correctly, it disrupts these important developmental processes, leading to the features of the syndrome. [PMID:33671234]
References
- Adam MP, Bick S, Mirzaa GM. KAT6B Disorders. 1993. PMID: 23236640
- Lonardo F, Lonardo MS, Acquaviva F. Say-Barber-Biesecker-Young-Simpson syndrome and Genitopatellar syndrome: Lumping or splitting? Clinical genetics. 2019. PMID: 28857140
- Campeau PM, Lu JT, Dawson BC. The KAT6B-related disorders genitopatellar syndrome and Ohdo/SBBYS syndrome have distinct clinical features reflecting distinct molecular mechanisms. Human mutation. 2012. PMID: 22715153
- Bergmann C, Spranger S, Javaher P. Genitopatellar syndrome, sensorineural hearing loss, and cleft palate. Oral and maxillofacial surgery. 2011. PMID: 20182757
- Abdul-Rahman OA, La TH, Kwan A. Genitopatellar syndrome: expanding the phenotype and excluding mutations in LMX1B and TBX4. American journal of medical genetics. Part A. 2006. PMID: 16761293
- Radvanszky J, Hyblova M, Durovcikova D. Complex phenotypes blur conventional borders between Say-Barber-Biesecker-Young-Simpson syndrome and genitopatellar syndrome. Clinical genetics. 2017. PMID: 27452416
- Alzanbaqi S, Ghibban A, Natto ZS. The Intersection of Genitopatellar Syndrome and Oral Health: A Case Report at Saudi Arabia. Case reports in dentistry. 2025. PMID: 40843254
- Back W, Mierzwa A, Mahfooz N. Genitopatellar Syndrome With a Novel Variant in the KAT6B Gene: Supporting Spectrum Delineation. Cureus. 2024. PMID: 39445296